Carboplatin-Taxol for Lung Cancer

Carboplatin is a platinum compound. It binds DNA. That blocks the cell from copying it. Paclitaxel, sold for years as Taxol, is a taxane. It acts at the other end of cell division. It freezes the microtubule scaffolding. A cell needs that scaffolding to pull its chromosomes apart.

Pairing them is deliberate. Two mechanisms. Two different harm profiles. Carboplatin hits the bone marrow hardest. Paclitaxel hits nerves and can set off allergic reactions. Neither one doubles the other's worst effect.

One thing to settle early. This pairing belongs to non-small cell lung cancer. For small cell lung cancer, NCI says platinum plus etoposide is the standard regimen.

NCI's summary shows this backbone in several places. Knowing which one applies matters more than the drug names.

Before surgery, weekly carboplatin and paclitaxel is one regimen tested with radiation to shrink a tumor first. The NADIM trial took people with resectable stage IIIA disease. They had paclitaxel and carboplatin plus nivolumab every 21 days for three cycles. A year of nivolumab followed surgery. At a median 60 months, 5-year progression-free survival was 65.0%. Overall survival was 69.3%.

For stage III disease, weekly carboplatin and paclitaxel was the chemotherapy given with radiation in RTOG 0617. That trial matters for a negative result. Raising radiation from 60 Gy to 74 Gy made survival worse. The hazard ratio was 1.38. Grade 3 esophagitis rose from 7% to 21%. So 60 Gy stayed standard.

For advanced disease, the pairing partners immunotherapy. KEYNOTE-407 enrolled untreated metastatic squamous NSCLC. People got pembrolizumab by vein or placebo. Both arms also got carboplatin with paclitaxel or nab-paclitaxel every 3 weeks for four cycles. Five-year overall survival was 18.4% with pembrolizumab and 9.7% with placebo.

After surgery, the story is weaker. CALGB 9633 gave adjuvant carboplatin and paclitaxel after removal of stage IB disease. At a median 74 months, survival was no different from observation.

Most chemotherapy is dosed by body surface area. Carboplatin is not. Its clearance is driven by glomerular filtration rate. So the label uses the Calvert formula instead.

Total dose in mg equals the target AUC multiplied by the sum of GFR and 25.

AUC means area under the concentration-time curve. It is a measure of total drug exposure. So the dose is set by how fast the kidneys clear the drug. The label notes GFR often falls with age. It directs that GFR-based formulas be used in older patients to keep toxicity down.

This is worth asking about directly. Two numbers produced the dose on the bag. The target AUC, and the kidney function estimate.

Paclitaxel carries a boxed warning. In trials, 2% to 4% of people had anaphylaxis or a severe hypersensitivity reaction. That means breathlessness, low blood pressure needing treatment, angioedema, or widespread hives. Fatal reactions have happened despite premedication.

So the label directs that all patients be pretreated. That means corticosteroids, diphenhydramine, and an H2 antagonist such as cimetidine or ranitidine. It is the reason for steroid tablets the night before, or extra bags before the paclitaxel starts.

The label draws a line between mild and severe. Minor flushing, skin changes, breathlessness, low blood pressure, or a fast heartbeat do not require stopping. Low blood pressure needing treatment does. So does breathlessness needing bronchodilators, angioedema, or widespread hives. Anyone with a severe reaction is not rechallenged with the drug.

Vital signs are checked often during the first hour of the infusion, which is when most of this happens.

Carboplatin's dose-limiting toxicity is bone marrow suppression. That means low white cells, low neutrophils, and low platelets. The label puts the median nadir at day 21 for single-agent carboplatin. Courses are generally not repeated until those counts recover.

Platelets are the telling feature. In head-to-head trials, the carboplatin regimen caused more thrombocytopenia than the cisplatin one. The label's tables set that at a platelet count under 100,000 per mm3. Older adults on carboplatin were more likely to develop severe thrombocytopenia than younger ones.

Fever during the low-count window is an emergency, not something to sleep on. See the last section for what to do. More on that window is in low white blood cells during chemotherapy.

Peripheral neuropathy is frequent with paclitaxel. Numbness, tingling, or burning starts in the fingertips and toes. It works inward from there. The label says severe symptoms are unusual. When they do develop, they require a 20% dose cut for all later courses.

That number is worth knowing. Neuropathy is the side effect people most often fail to mention. It does not hurt in a way that feels urgent. It can also become permanent. More on it is in peripheral neuropathy.

Hair loss is expected with paclitaxel. Most people also see fatigue and nausea. The pair comes with the usual infusion-day anti-sickness plan.

Four things are worth pinning down in writing. First, which setting this is: before surgery, with radiation, or for advanced disease. Second, whether an immunotherapy drug is being added. That changes both the cycle length and the side-effect list. Third, how many cycles run before the next scan. Fourth, the after-hours number, plus the exact temperature the team wants to hear about.

For how stage drives these choices, see lung cancer treatment by stage and immunotherapy.

• Call 911 or go to an emergency department if your breathing tightens, your face, lips or tongue swell, hives spread over your body, or you feel your heart pound and the room tip. Paclitaxel's boxed warning covers exactly this, and severe reactions have proved fatal even after premedication. During the infusion, tell the nurse the moment anything changes.
• A temperature of 100.4°F (38°C) or higher is an emergency. Ring the 24-hour chemotherapy number at once, and if nobody picks up, go to an emergency department and say you are on chemotherapy. CDC treats fever during chemotherapy as an emergency because infection can move fast while neutrophils are low. Shaking chills count even if the thermometer has not caught up.
• Call your care team the same day if you bruise without knocking anything, a nosebleed will not settle, you see blood in urine or stool, or a cut keeps oozing. Platelets dip further on this pairing than on the cisplatin version.
• Call your care team within a day or two if numbness, tingling or burning starts in your fingertips or toes, or you cannot keep fluids down. Neuropathy can become permanent, and the dose can be cut to protect you.

• CDC — Fever and Cancer Treatment
• NCI PDQ — Non-Small Cell Lung Cancer Treatment (Health Professional Version)
• NCI PDQ — Small Cell Lung Cancer Treatment (Health Professional Version)
• DailyMed — Paclitaxel Injection prescribing information
• DailyMed — Carboplatin Injection prescribing information
• NCI — Paclitaxel
• NCI — Carboplatin